Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Clinical Epidemiology|March 17, 2025
Postoperative Adverse Outcomes in Patients With Frailty Undergoing Urologic Surgery Among American Patients: A Propensity-Score Matched Retrospective Cohort StudyCheng-Wei Hsu, Chuen-Chau Chang, Fai Lam, et al.
Toxicology and Applied Pharmacology|June 17, 2020
Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophagesAlexander T H Wu, Prateeti Srivastava, Vijesh Kumar Yadav, et al.
Journal of Plant Physiology|November 18, 2008
Expression and regulation of two novel anther-specific genes in Lilium longiflorumJhih-Deng Tzeng, Ssu-Wei Hsu, Mei-Chu Chung, et al.
Tissue Engineering. Part C, Methods|May 17, 2013
Establishment of a promising human nucleus pulposus cell line for intervertebral disc tissue engineeringMing-Che Liu, Wei-Hong Chen, Ling-Chiao Wu, et al.
Biology|May 27, 2023
Immunologic, Anti-Inflammatory, and Anti-Muscle Damage Profile of Supplemented Vitamin D3 in Healthy Adults on Strenuous Endurance ExerciseMing-Che Liu, Pei-Wei Weng, Sheng-Chang Chen, et al.
Plos One|November 11, 2016
Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy MiceSung-Hsun Yu, Navneet Kumar Dubey, Wei-Shan Li, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2019
Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progressionKoichi Kitagawa, Katsumi Shigemura, Shian-Ying Sung, et al.
Vaccines|December 23, 2023
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled StudyChia En Lien, Ming-Che Liu, Ning-Chi Wang, et al.
Vaccine|December 9, 2019
A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II studySung-Ching Pan, Wei-Ting Hsu, Wen-Sen Lee, et al.
Biomaterials|April 6, 2013
Preferential therapy for osteoarthritis by cord blood MSCs through regulation of chondrogenic cytokinesWen-Cheng Lo, Wei-Hong Chen, Tzu-Chieh Lin, et al.
Pageof 6